Shares of Immunoprecise Antibodies (NASDAQ:IPA), also known as IPA, were up 30% Thursday after its subsidiary BioStrand unveiled an advanced foundation AI model for drug discovery that utilizes large ...
AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a global leader in AI-powered antibody discovery and development, today announced a strategic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback